Skip to main content

Table 1 Patient characteristics and intraoperative data

From: Administration of HES in elderly patients undergoing hip arthroplasty under spinal anesthesia is not associated with an increase in renal injury

Groups

Male/Female

Age (yr)

ASA status (I/II/III)

Operation time (min)

Fluid infusion (ml)

Blood loss (ml)

Patients needing phenylephrine, no.(%)

Phenylephrine dose per patient(mg)

Length of stay (d)

HES

31/28

75.9 ± 7.5

39/15/5

56 ± 4

490 ± 30

100 ± 40

2(3.4)

0.1 ± 0.04

10.5 ± 1.7

LR

29/30

76.4 ± 8.1

37/14/8

58 ± 5

510 ± 20

120 ± 50

5(8.5)

0.15 ± 0.06

11.2 ± 1.1

  1. Values are no. (%) or means(SD)
  2. Patients in group LR received intraoperative placebo Lactate Ringers’ at a dose of 7.5 ml/kg; Patients in group HES received 6% HES 130/0.4 at a dose of 7.5 ml/kg in the first hour of surgery, and then, Lactate Ringers’ was administrated 5 ml/kg until the end of the surgery. All data were presented as mean ± SD or number of patients. ASA American Society of Anaesthesiologists, HES 6% hydroxyethyl starch 130/0.4, LR Lactate Ringers